glp-1 attorney Chicago Matt Williams discusses mounting lawsuits against makers of weight loss drugs Ozempic (GLP-1 Drugs) Lawsuit -
Description
1 (the Budget Reconciliation Act of 2025) take effect
In the SURMOUNT-4 trial, withdrawing tirzepatide after initial weight loss led to weight regain, while continued treatment maintained and extended weight reduction
Diabetes Care 33(2):428433 Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M et al (2015) Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
Informed Consent Informed consent does not apply
About the Authors: Dr
